927 related articles for article (PubMed ID: 16772330)
1. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
2. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].
Matsuura T
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845
[TBL] [Abstract][Full Text] [Related]
3. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse.
Tokui K; Adachi H; Waza M; Katsuno M; Minamiyama M; Doi H; Tanaka K; Hamazaki J; Murata S; Tanaka F; Sobue G
Hum Mol Genet; 2009 Mar; 18(5):898-910. PubMed ID: 19066230
[TBL] [Abstract][Full Text] [Related]
4. [Molecular pathogenesis of motor neuron diseases].
Sobue G
Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic CAG repeat length in the androgen receptor gene and association with neurodegeneration in a heterozygous female carrier of Kennedy's disease.
Greenland KJ; Beilin J; Castro J; Varghese PN; Zajac JD
J Neurol; 2004 Jan; 251(1):35-41. PubMed ID: 14999487
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor function in motor neuron survival and degeneration.
Cary GA; La Spada AR
Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):479-94, viii. PubMed ID: 18625411
[TBL] [Abstract][Full Text] [Related]
8. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
Banno H; Adachi H; Katsuno M; Suzuki K; Atsuta N; Watanabe H; Tanaka F; Doyu M; Sobue G
Ann Neurol; 2006 Mar; 59(3):520-6. PubMed ID: 16358333
[TBL] [Abstract][Full Text] [Related]
9. [In vitro aggregation and cellular toxicity of mutant androgen receptor protein in spinal and bulbar muscular atrophy].
Kobayashi Y; Li M; Sobue G
Nihon Rinsho; 1999 Apr; 57(4):874-9. PubMed ID: 10222782
[TBL] [Abstract][Full Text] [Related]
10. [From gene to disease; androgen receptor gene, androgen insensitivity syndrome, and spinal and bulbar muscle atrophy].
Boehmer AL; Brinkmann AO; Niermeijer MF; Halley DJ; Drop SL
Ned Tijdschr Geneeskd; 2001 Dec; 145(48):2326-8. PubMed ID: 11766302
[TBL] [Abstract][Full Text] [Related]
11. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.
Waza M; Adachi H; Katsuno M; Minamiyama M; Sang C; Tanaka F; Inukai A; Doyu M; Sobue G
Nat Med; 2005 Oct; 11(10):1088-95. PubMed ID: 16155577
[TBL] [Abstract][Full Text] [Related]
12. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.
Suzuki K; Katsuno M; Banno H; Takeuchi Y; Atsuta N; Ito M; Watanabe H; Yamashita F; Hori N; Nakamura T; Hirayama M; Tanaka F; Sobue G
Brain; 2008 Jan; 131(Pt 1):229-39. PubMed ID: 18056738
[TBL] [Abstract][Full Text] [Related]
13. [Animal models of neurodegenerative diseases on the road to disease-modifying therapy: spinal and bulbar muscular atrophy].
Sobue G
Rinsho Shinkeigaku; 2007 Nov; 47(11):941-3. PubMed ID: 18210842
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Adachi H; Waza M; Banno H; Suzuki K; Tanaka F; Doyu M; Sobue G
Exp Neurol; 2006 Jul; 200(1):8-18. PubMed ID: 16513111
[TBL] [Abstract][Full Text] [Related]
15. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.
Katsuno M; Adachi H; Doyu M; Minamiyama M; Sang C; Kobayashi Y; Inukai A; Sobue G
Nat Med; 2003 Jun; 9(6):768-73. PubMed ID: 12754502
[TBL] [Abstract][Full Text] [Related]
16. Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner.
Kobayashi Y; Miwa S; Merry DE; Kume A; Mei L; Doyu M; Sobue G
Biochem Biophys Res Commun; 1998 Nov; 252(1):145-50. PubMed ID: 9813160
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration.
Sopher BL; Thomas PS; LaFevre-Bernt MA; Holm IE; Wilke SA; Ware CB; Jin LW; Libby RT; Ellerby LM; La Spada AR
Neuron; 2004 Mar; 41(5):687-99. PubMed ID: 15003169
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G
Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045
[TBL] [Abstract][Full Text] [Related]
19. Kennedy's disease: pathogenesis and clinical approaches.
Greenland KJ; Zajac JD
Intern Med J; 2004 May; 34(5):279-86. PubMed ID: 15151675
[TBL] [Abstract][Full Text] [Related]
20. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.
Yang Z; Chang YJ; Yu IC; Yeh S; Wu CC; Miyamoto H; Merry DE; Sobue G; Chen LM; Chang SS; Chang C
Nat Med; 2007 Mar; 13(3):348-53. PubMed ID: 17334372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]